Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Kidney Disease Stage 3: early-phase trial registry
1 of 5 indexed Chronic Kidney Disease Stage 3 trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Chronic Kidney Disease Stage 3: 5 US clinical trials tracked, 1 recruiting.
Chronic Kidney Disease Stage 3 is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is 3-C Institute for Social Development, running 1 of these trials.
Enrollment posture brief
Registry condition chronic-kidney-disease-stage-3
OPEN 1 | RECR 20% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Chronic Kidney Disease Stage 3 lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Kidney Disease Stage 3 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Kidney Disease Stage 3 is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chronic Kidney Disease Stage 3 research.
3-C Institute for Social Development accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Kidney Disease Stage 3 enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Chronic Kidney Disease Stage 3 splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)
AION Healthspan
NCT06721143
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Renalytix AI
NCT05198284
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
University of Rochester
NCT05797506
Preserving Kidney Function in Children With Chronic Kidney Disease
Children's Hospital of Philadelphia
NCT05169411
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
3-C Institute for Social Development
NCT05630729
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Kidney Disease Stage 3 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Kidney Disease Stage 3 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Kidney Disease Stage 3 page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Chronic Kidney Disease Stage 3 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- 3-C Institute for Social Development sponsors the most Chronic Kidney Disease Stage 3 trials on record, review their full trial history before evaluating a specific study. See 3-C Institute for Social Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Kidney Disease Stage 3 condition card totals 5 registered trials; most-linked intervention Urine protein; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.